[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334245-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334245-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","baiap2l2-promotes-the-malignancy-of-hepatocellular-carcinoma-via-gabpb1-mediated-reactive-oxygen-species-imbalance-research-summary","BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance - Research summary","","BAIAP2L2 is upregulated in hepatocellular carcinoma (HCC) and acts as an independent prognostic factor for overall survival. Functional data show that BAIAP2L2 enhances proliferation, metastasis, stemness, and cell-cycle progression while inhibiting apoptosis. Mechanistically, NFκB1 directly binds the BAIAP2L2 promoter to drive transcription. BAIAP2L2 interacts with GABPB1, suppressing ubiquitin-mediated degradation and promoting nuclear translocation, which disrupts reactive oxygen species (ROS) balance. This cascade strengthens HCC malignancy and decreases sensitivity to lenvatinib, highlighting BAIAP2L2 as a potential biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/baiap2l2-promotes-the-malignancy-of-hepatocellular-carcinoma-via-gabpb1-mediated-reactive-oxygen-species-imbalance-research-summary/334245/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/baiap2l2-promotes-the-malignancy-of-hepatocellular-carcinoma-via-gabpb1-mediated-reactive-oxygen-species-imbalance-research-summary/334245.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does BAIAP2L2 play in hepatocellular carcinoma (HCC)?","Question",{"text":63,"@type":64},"BAIAP2L2 is upregulated in HCC and promotes malignancy. It enhances proliferation, metastasis, stemness, and cell-cycle progression while inhibiting apoptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is BAIAP2L2 transcriptionally regulated in HCC?",{"text":68,"@type":64},"NFκB1 stimulates BAIAP2L2 transcription by directly binding to its promoter region.",{"name":70,"@type":61,"acceptedAnswer":71},"How does BAIAP2L2 affect GABPB1 and reactive oxygen species (ROS)?",{"text":72,"@type":64},"BAIAP2L2 interacts with GABPB1 to inhibit ubiquitin-mediated degradation and facilitate its nuclear translocation. This regulation suppresses ROS levels, promoting cancer properties in HCC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334245,1790194311,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","[www.nature.com/cgt](www.nature.com/cgt) Cancer Gene Therapy  \nARTICLE OPEN   \nBAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance  \nWenbo Jia1,2,5, Bin Xu1,2,5, Liang Yu3,5, Yanzhi Feng1,2, Jinyi Wang1,2, Chao Xu1,2, Litao Liang 1,2, Yongping Zhou4 ✉, Wenzhou Ding 1,2 ✉ and Lianbao Kong 1,2 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Hepatocellular carcinoma (HCC) is a common type of cancer worldwide and ranks as the fourth leading cause of cancer-related deaths. This research investigation identiﬁed an upregulation of BAI1-associated protein 2-like 2 (BAIAP2L2) in HCC tissues, which was found to be an independent prognostic factor for overall survival in HCC patients. BAIAP2L2 was observed to enhance cell proliferation, metastasis, stemness, cell cycle progression, and inhibit apoptosis in HCC. Mechanistically, NFκB1 was found to stimulate BAIAP2L2 transcription by directly binding to its promoter region. BAIAP2L2 interacts with GABPB1 to inhibit its ubiquitin-mediated degradation and promote its nuclear translocation. BAIAP2L2 inhibits the levels of reactive oxygen species (ROS) by regulating GABPB1, thereby promoting cancer properties in HCC and reducing the sensitivity of HCC to lenvatinib. In summary, this study elucidates the role and |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| underlying mechanism of BAIAP2L2 in HCC, providing a potential biomarker and therapeutic target for this disease. |  |  |\n|  | Cancer Gene Therapy (2024) 31:1868–1883; [https://doi.org/10.1038/s41417-024-00841-0](https://doi.org/10.1038/s41417-024-00841-0) |  |\n|  |  |  |\n\nINTRODUCTION  \nHCC is the predominant histological subtype of primary liver cancer, accounting for ~80% of cases globally [1] . In terms of global cancer statistics, liver cancer ranks sixth in new incidence and third in mortality rate [2, 3] . Surgical resection or transplantation is considered the most effective treatment for early-stage HCC. However, the majority of HCC patients are asymptomatic in the early stages and are often diagnosed at an advanced stage [4] . Despite advancements in the prevention, diagnosis, and intervention of HCC, outcomes remain unfavorable. Therefore, there is a pressing need to enhance the investigation of the molecular mechanisms underlying the pathogenesis of HCC.  \nBAIAP2L2, a member of the I-BAR protein family, has been implicated in various types of cancer, including lung cancer [5], osteosarcoma [6], gastric cancer [7], and prostate cancer [8]. Inhibition of BAIAP2L2 has been found to restrict the proliferation of osteosarcoma cells [6]. In gastric cancer, BAIAP2L2 has been shown to promote cancer progression through the activation of the AKT/ mTOR and Wnt3a/beta-catenin signaling pathways [7]. Additionally, BAIAP2L2 has been identiﬁed as a potential therapeutic target for EGFR wild-type cancers with low PD-L1 expression [9]. In the study conducted by Wei et al. on HCC, it was found that BAIAP2L2 may impact the prognosis of HCC by regulating immunity, methylation, and cuproptosis through the use of bioinformatics technology [10]. However, the clinical and pathological signiﬁcance of BAIAP2L2 in HCC remains unclear, and no studies have been conducted to elucidate the functional role of BAIAP2L2 in the development of HCC.  \nIn this study, we discovered that the expression of BAIAP2L2 was increased in HCC and found that it was an independent prognostic factor for the overall survival of HCC patients. BAIAP2L2 was found to enhance HCC cell proliferation, metastasis, stemness, cell cycle progression, and inhibit apoptosis. NF-κB1 was identiﬁed as a crucial factor in the upregulation of BAIAP2L2 in HCC. Additionally, we demonstrated that BAIAP2L2 interacts with GAbinding protein transcription factor subunit beta 1 (GABPB1), inhibiting the protease degradation of GABPB1 by suppressing its ubiquitination and facilitating its translocation ","cbCaisD720L1CVrR","https://ap.wps.com/l/cbCaisD720L1CVrR","pdf",8054789,16,"English","# Introduction\n# Materials and Methods\n## Cell lines and human tissue","[{\"question\":\"What role does BAIAP2L2 play in hepatocellular carcinoma (HCC)?\",\"answer\":\"BAIAP2L2 is upregulated in HCC and promotes malignancy. It enhances proliferation, metastasis, stemness, and cell-cycle progression while inhibiting apoptosis.\"},{\"question\":\"How is BAIAP2L2 transcriptionally regulated in HCC?\",\"answer\":\"NFκB1 stimulates BAIAP2L2 transcription by directly binding to its promoter region.\"},{\"question\":\"How does BAIAP2L2 affect GABPB1 and reactive oxygen species (ROS)?\",\"answer\":\"BAIAP2L2 interacts with GABPB1 to inhibit ubiquitin-mediated degradation and facilitate its nuclear translocation. This regulation suppresses ROS levels, promoting cancer properties in HCC.\"}]","BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance - Research summary | PDF",1790005937]